TG Therapeutics Inc (STU:NKB2)
€ 21.995 0.3 (1.38%) Market Cap: 3.41 Bil Enterprise Value: 3.31 Bil PE Ratio: 40.77 PB Ratio: 21.33 GF Score: 73/100

TG Therapeutics Inc (STU:NKB2) Transcripts

  • 1